Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $9.73 Million - $13.2 Million
36,110 Added 779.41%
40,743 $13.2 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $1.62 Million - $1.96 Million
4,633 New
4,633 $1.66 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $10.7 Million - $12.9 Million
-25,653 Reduced 61.74%
15,895 $7.61 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $10.5 Million - $13.6 Million
29,914 Added 257.13%
41,548 $17.5 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $2.81 Million - $3.83 Million
-6,804 Reduced 36.9%
11,634 $4.85 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $12.2 Million - $15.7 Million
-26,259 Reduced 58.75%
18,438 $9.13 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $10.2 Million - $14.3 Million
19,427 Added 76.88%
44,697 $25.2 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $11.3 Million - $12.7 Million
15,973 Added 171.81%
25,270 $19.1 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $4.37 Million - $5.48 Million
6,640 Added 249.91%
9,297 $6.94 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $697,157 - $784,689
-1,209 Reduced 31.27%
2,657 $1.71 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $1.66 Million - $2.01 Million
-3,039 Reduced 44.01%
3,866 $2.21 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $3.34 Million - $4.21 Million
-6,542 Reduced 48.65%
6,905 $4.03 Million
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $274,475 - $323,502
604 Added 4.7%
13,447 $6.93 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $1.36 Million - $2.01 Million
4,075 Added 46.48%
12,843 $5.8 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $15.6 Million - $19.9 Million
-48,622 Reduced 84.72%
8,768 $3.07 Million
Q4 2019

Feb 18, 2020

BUY
$319.73 - $374.2 $12.6 Million - $14.8 Million
39,522 Added 221.19%
57,390 $21.2 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $1.07 Million - $1.21 Million
3,499 Added 24.35%
17,868 $5.95 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $3.6 Million - $3.92 Million
-12,553 Reduced 46.63%
14,369 $4.49 Million
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $2.58 Million - $3.65 Million
11,512 Added 74.7%
26,922 $8.23 Million
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $6.62 Million - $9.3 Million
-30,081 Reduced 66.13%
15,410 $3.58 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $6.91 Million - $7.79 Million
23,893 Added 110.63%
45,491 $14.2 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $3.48 Million - $4.33 Million
14,254 Added 194.09%
21,598 $6.23 Million
Q1 2018

May 15, 2018

BUY
$233.97 - $274.11 $1.72 Million - $2.01 Million
7,344 New
7,344 $1.84 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.